These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 34039493)

  • 1. The microbiota in cirrhosis and its role in hepatic decompensation.
    Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
    J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
    Trebicka J; Bork P; Krag A; Arumugam M
    Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):167-180. PubMed ID: 33257833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
    Trebicka J; Hernaez R; Shawcross DL; Gerbes AL
    Gut; 2024 May; 73(6):1015-1024. PubMed ID: 38527788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure.
    Kim SE; Park JW; Kim HS; Jang MK; Suk KT; Kim DJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute-on-chronic liver failure in cirrhosis.
    Arroyo V; Moreau R; Kamath PS; Jalan R; Ginès P; Nevens F; Fernández J; To U; García-Tsao G; Schnabl B
    Nat Rev Dis Primers; 2016 Jun; 2():16041. PubMed ID: 27277335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
    Hoshi H; Chu PS; Yoshida A; Taniki N; Morikawa R; Yamataka K; Noguchi F; Kasuga R; Tabuchi T; Ebinuma H; Saito H; Kanai T; Nakamoto N
    PLoS One; 2021; 16(4):e0250062. PubMed ID: 33848309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.
    Liu J; MacNaughtan J; Kerbert AJC; Portlock T; Martínez Gonzalez J; Jin Y; Clasen F; Habtesion A; Ji H; Jin Q; Phillips A; De Chiara F; Ingavle G; Jimenez C; Zaccherini G; Husi K; Rodriguez Gandia MA; Cordero P; Soeda J; McConaghy L; Oben J; Church K; Li JV; Wu H; Jalan A; Gines P; Solà E; Eaton S; Morgan C; Kowalski M; Green D; Gander A; Edwards LA; Cox IJ; Cortez-Pinto H; Avery T; Wiest R; Durand F; Caraceni P; Elosua R; Vila J; Pavesi M; Arroyo V; Davies N; Mookerjee RP; Vargas V; Sandeman S; Mehta G; Shoaie S; Marchesi J; Albillos A; Andreola F; Jalan R
    Gut; 2024 Jun; 73(7):1183-1198. PubMed ID: 38621924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mechanisms linking gut microbiota and portal hypertension.
    Baffy G
    Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events.
    Gustot T; Stadlbauer V; Laleman W; Alessandria C; Thursz M
    J Hepatol; 2021 Jul; 75 Suppl 1():S36-S48. PubMed ID: 34039491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development and features of infection in patients with acute-on-chronic liver failure and its influence on disease progression and prognosis].
    Cao ZJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):6-9. PubMed ID: 29804354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients.
    Yin S; Wang SJ; Gu WY; Zhang Y; Chen LY; Li H
    J Dig Dis; 2017 May; 18(5):292-301. PubMed ID: 28485081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?
    Piano S; Angeli P
    Clin Liver Dis; 2021 May; 25(2):357-372. PubMed ID: 33838855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.